◆英語タイトル:NeoDynamics AB - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME449901PD
◆発行会社(調査会社):
GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
NeoDynamics AB (NeoDynamics) is a medical technology company that develops medical solutions for the early detection and treatment of cancer. The company develops the NeoNavia biopsy system that helps to collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of breast abnormalities. Its NeoNavia biopsy system is designed to manage challenges related to axillary lymph node biopsies such as injuring small or large blood vessels, injuring nerves, injuring the thoracic muscles and pneumothorax. The company offers medical solutions to clinicians and physicians. NeoDynamics is headquartered in Stockholm, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeoDynamics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
NeoDynamics AB Company Overview
NeoDynamics AB Company Snapshot
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview
NeoDynamics AB – Pipeline Analysis Overview
NeoDynamics AB – Key Facts
NeoDynamics AB – Major Products and Services
NeoDynamics AB Pipeline Products by Development Stage
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB Pipeline Products Overview
Cytotest
Cytotest Product Overview
NeoNavia Biopsy System
NeoNavia Biopsy System Product Overview
NeoNavia Biopsy System Clinical Trial
NeoNavia duo
NeoNavia duo Product Overview
NeoNavia duo Clinical Trial
Preferential Radiofrequency Ablation (PRFA) Device
Preferential Radiofrequency Ablation (PRFA) Device Product Overview
NeoDynamics AB – Key Competitors
NeoDynamics AB – Key Employees
NeoDynamics AB – Locations And Subsidiaries
Head Office
Recent Developments
NeoDynamics AB, Recent Developments
Feb 05, 2020: NeoDynamics full-year report 2019
Feb 03, 2020: A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.
Nov 27, 2019: NeoDynamics signs manufacturing agreement for NeoNavia
Nov 21, 2019: NeoDynamics third quarter jul-sep 2019
Oct 29, 2019: NeoDynamics receives regulatory approval for new Breast Cancer biopsy system
Sep 03, 2019: Redeye initiates coverage of NeoDynamics
Aug 28, 2019: NeoDynamics half-year report 2019
May 21, 2019: NeoDynamics – Quarterly report January-March 2019
Apr 26, 2019: NeoDynamics receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
Apr 10, 2019: New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview
NeoDynamics AB Pipeline Products by Equipment Type
NeoDynamics AB Pipeline Products by Indication
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB, Key Facts
NeoDynamics AB, Major Products and Services
NeoDynamics AB Number of Pipeline Products by Development Stage
NeoDynamics AB Pipeline Products Summary by Development Stage
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB Ongoing Clinical Trials Summary
Cytotest - Product Status
Cytotest - Product Description
NeoNavia Biopsy System - Product Status
NeoNavia Biopsy System - Product Description
NeoNavia Biopsy System - Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes
NeoNavia Biopsy System - Percutaneous Ultrasound-Guided Biopsy Evaluated for Axillary Lymph Node Sampling Efficacy: PULSE
NeoNavia duo - Product Status
NeoNavia duo - Product Description
NeoNavia duo - Evaluation of NeoNavia Biopsy System in Breast Cancer Patients
Preferential Radiofrequency Ablation (PRFA) Device - Product Status
Preferential Radiofrequency Ablation (PRFA) Device - Product Description
NeoDynamics AB, Key Employees
Glossary